Pharmacy DEA Registration When Buying an Existing Pharmacy

A pharmacy sale does not carry the seller's DEA registration to the new owner. That registration belongs to the seller alone, and a buyer who dispenses controlled substances before its own registration is in place is operating without the federal authority the law requires. A buyer who treats the closing date as the effective date of the new registration can end up with a dispensing gap: full shelves and a pharmacist-in-charge who cannot legally fill a controlled-substance prescription until DEA issues a new Certificate of Registration. A buyer who lines up the application, the transfer-day inventory, and the recordkeeping ahead of the closing date is the one who avoids it.

Why the Registration Does Not Transfer With the Sale

Under 21 CFR 1301.52(b), no registration, or any authority it confers, may be assigned or transferred except on conditions DEA specifically designates, and then only with the agency's written consent. A purchase agreement that assigns the pharmacy's lease and state pharmacy permit does not assign the DEA registration with them. 21 CFR 1301.13 separately requires anyone not already registered to apply for a new one, and bars that person from engaging in any activity for which registration is required until DEA grants the application and issues a Certificate of Registration. For a buyer, the new entity's own registration, not the seller's old number, is what has to be in place before the first controlled-substance prescription is filled.

Timing the New Application Before Closing

Neither section sets a fixed processing time for a new pharmacy's DEA application, and that is the planning problem. A buyer who waits until the purchase agreement is signed to start the application is relying on DEA's internal processing speed to land before the closing date, a variable the buyer does not control. Filing as soon as the deal is reasonably certain, rather than after signing, lets the state pharmacy license, typically a prerequisite DEA checks before acting, and the DEA application clear in parallel. A closing date set before the new registration is issued is a date the pharmacy cannot legally dispense controlled substances under, regardless of how the purchase agreement defines the transfer.

The Transfer-Day Controlled Substance Inventory

Under 21 CFR 1304.11(b), every person who keeps controlled-substance records must take an inventory on the date they first engage in dispensing, which for a new pharmacy owner is the date the new registration becomes operative. 21 CFR 1301.52(e)(1) gives the buyer and seller a narrow way to move inventory on that date, but only if the seller first gave the DEA Special Agent in Charge at least 14 days' written notice of the transfer under 21 CFR 1301.52(d), and the Special Agent in Charge has not told the seller the transfer may not occur. One complete inventory, taken on the date of transfer, serves double duty as the seller's final inventory and the buyer's initial inventory, with a copy kept in each party's records. Schedule I and II substances moved that day require the DEA order forms specified in 21 CFR part 1305; Schedule III through V do not. Counting stock that was never on the shelf, or missing stock that was, is the kind of discrepancy an inventory reconciliation surfaces months later, when it is harder to explain.

Records the Buyer Must Obtain From the Seller

The same provision, 21 CFR 1301.52(e)(2), requires the seller to transfer every Part 1304 record tied to the controlled substances changing hands, not only the inventory count. The seller stays accountable for whether those records were accurate before the transfer date; the buyer's job afterward is keeping them intact, not re-verifying them. Under 21 CFR 1301.52(e)(3), the seller files a report marked "Final" showing the disposition of its controlled substances, and the buyer's own initial report picks up transactions starting the next day. A buyer that takes the physical inventory without the records behind it inherits a documentation gap that can surface later as a DEA order to show cause, when the facts are harder to reconstruct. A new registration number also means the pharmacy's electronic prescribing of controlled substances compliance setup has to point to that number before the first e-prescription comes through under it.

The registration stays with the seller unless DEA itself approves a transfer in writing. A purchase agreement cannot move it on its own, and 21 CFR 1301.52(b) makes that written consent the exception, not the rule.

Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.

Why Early Legal Counsel Is Critical

It is critical that pharmacy buyers retain experienced healthcare defense counsel before signing a purchase agreement that depends on timely DEA registration. Early legal intervention can protect the buyer's closing timeline, confirm the transfer-day inventory and records meet federal requirements, and help the buyer avoid inheriting a seller's documentation gap. Delaying legal review until days before closing can leave a new pharmacy unable to dispense controlled substances on opening day.

How Health Law Alliance Can Help

Health Law Alliance defends pharmacies and pharmacy buyers nationwide in DEA registration matters, including the timing, inventory, and recordkeeping questions that come up whenever a pharmacy changes hands.

If your pharmacy is buying or selling a location and needs the new registration, inventory transfer, and records handled correctly before closing, contact Health Law Alliance's DEA defense team for a free, confidential consultation.